Abstract
ABSTRACT: 68Ga-prostate-specific membrane antigen (PSMA) PET/CT is a well-established imaging modality in patients with prostate cancer; however, PSMA expression is also reported in the tumor-associated neovasculature, including but not limited to hepatocellular carcinoma, breast cancer, and renal cell carcinoma. Herein, we present 2 patients diagnosed with different histopathological subtypes of renal cell carcinoma who underwent 68Ga-PSMA PET/CT before surgery. Both cases have different PSMA expression characteristics and are presented along with pathological findings.
Original language | English (US) |
---|---|
Pages (from-to) | e45-e46 |
Journal | Clinical nuclear medicine |
Volume | 47 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2022 |
Externally published | Yes |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging